Phosphoinositide 3-kinase (PI3K) family of signalling enzymes and their role in asthma

Drug Discovery Today: Disease Mechanisms

Volumn 3, Issue 1, 2006, Pages 63-69

  Walker, Christoph ^a   Thomas, Matthew ^a   Edwards, Matthew J ^a  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANTIASTHMATIC AGENT; GLUCOCORTICOID; ISOENZYME; PHOSPHATIDYLINOSITOL 3 KINASE; WORTMANNIN;

ALLERGIC ASTHMA; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; DISEASE MODEL; DRUG MECHANISM; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; EOSINOPHIL; HUMAN; INFLAMMATION; INFLAMMATORY CELL; MAST CELL; NONHUMAN; PATHOGENESIS; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 33745918668     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2006.02.004     Document Type: Review

References (40)

1. Elias J.A., et al. New insights into the pathogenesis of asthma. J. Clin. Invest. 111 (2003) 291-297
2. Banes P.J. New drugs for asthma. Nat. Rev. Drug Discov. 3 (2004) 831-844
3. Wymann M.P., et al. Phosphoinositide 3-kinase gamma: a key modulator in inflammation and allergy. Biochem. Soc. Trans. 31 (2003) 275-280
4. Finan P., et al. PI3-kinase inhibition: a therapeutic target for respiratory disease. Biochem. Soc. Trans. 32 (2004) 378-382
5. Fruman D.A., et al. Phosphoinositide kinases. Annu. Rev. Biochem. 67 (1998) 481-507
6. Vanhaesebroeck B., et al. Synthesis and function of 3-phophorylated inositol lipids. Annu. Rev. Biochem. 70 (2001) 535-602
7. Walker E.H., et al. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin and staurosporine. Mol. Cell 6 (2000) 909-919
8. Anderson G.P., et al. Th2 and Th2-like cells in allergy and asthma: pharmacological perspectives. Trends Pharmacol. Sci. 15 (1994) 324-332
9. Robinson D.R., et al. Predominant Th2-like bronchoalveolar lavage T-lymphocyte population in atopic asthma. New Engl. J. Med. 326 (1992) 298-304
10. Corry D.B., et al. Induction and regulation of the IgE response. Nature 402 (1999) B18-B23
11. Bacharier L.B., et al. Molecular mechanisms of IgE regulation. J. Allergy Clin. Immunol. 105 (2000) S547-S558
12. Sanderson C.J. IL-5, eosinophils and disease. Blood 79 (1992) 3101-3109
13. Kane L.P., et al. The PI3-kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3. Immunol. Rev. 192 (2003) 7020
14. Myou S., et al. Blockade of inflammation and airway hyperresponsiveness in immune sensitized mice by dominant negative phophoinositide 3-kinase-TAT. J. Exp. Med. 198 (2003) 1573-1582
15. Fukao T., et al. Selective loss of gastrointestinal mast cells and impaired immunity in PI3K deficient mice. Nat. Immunol. 3 (2002) 295-304
16. Fukao T., et al. PI3K mediated negative feedback regulation of IL-12 production in DCs. Nat. Immunol. 3 (2002) 875-881
17. Fruman D.A. Towards an understanding of isoform specificity in phosphoinositide 3-kinase signalling in lymphocytes. Biochem. Soc. Trans. 32 (2004) 315-319
18. Okkenhaug K., et al. PI3K-ignalling in B and T cells: insights from gene targeted mice. Biochem. Soc. Trans. 32 (2003) 270-274
19. Reif K., et al. Differential roles for phosphoinositide 3-kinases, p110gamma and p110delta, in lymphocyte chemotaxis and homing. J. Immunol. 173 (2004) 2236-2240
20. Webb L.M., et al. T cell development requires the combined activities of the p110gamma and p110delta catalytic isoforms of phosphatidylinositol 3-kinase. J. Immunol. 175 (2005) 2783-2787
21. Swat W., et al. The essential role of PI3Kdelta and PI3Kgamma in thymocyte survival. Blood 107 (2006) 2415-2422
22. Lambrecht B.N. Dendritic cells and the regulation of the allergic immune response. Allergy 60 (2005) 271-282
23. Del Prete A., et al. Defective dendritic cell migration and activation of adaptive immunity in PI3Kgamma-deficient mice. EMBO J. 23 (2004) 3505-3515
24. Koyasu S. Role of class IA phosphoinositide 3-kinase in B lymphocyte development and functions. Biochem. Soc. Trans. 32 (2004) 320-325
25. Bilancio A., et al. Key role of the p100delta isoform of PI3K in B cell antigen and IL-4 receptor signalling - comparative analysis of genetic and pharmacological interference with p110delta function in B cells. Blood 107 (2006) 642-650
26. Hebeis B.J., et al. The p110delta subunit of phosphoinositide 3-kinase is required for the lipopolysaccharide response of mouse B cells. Biochem. Soc. Trans. 32 (2004) 789-791
27. Galli S.J. Mast cells and basophils. Curr. Opin. Hematol. 7 (2000) 32-39
28. Fukao T., et al. Role of phosphoinositide 3-kinase signalling in mast cells: new insights from knock out mouse studies. J. Mol. Med. 81 (2003) 524-535
29. 2+ influx by enhancing inositol 1,4,5-triphosphate production. J. Biol. Chem. 276 (2001) 17213-17220
30. Windmiller S.A., et al. Distinct phosphoinositide 3-kinases mediate mast cell degranulation in response to G protein coupled versus FcepsilonRI receptors. J. Biol. Chem. 278 (2003) 11874-11878
31. Ali K., et al. Essential role for the p110d phosphoinositide 3-kinase in the allergic response. Nature 431 (2004) 1007-1011
32. Laffargue M., et al. Phosphoinositide-3 kinase gamma is an essential amplifier of mast cell function. Immunity 16 (2002) 441-451
33. Lacy P., et al. Immune effector functions of eosinophils in allergic airway inflammation. Curr. Opin. Allergy Clin. Immunol. 1 (2001) 79-84
34. Palframan R.T., et al. Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by IL-5: the role of specific adhesion molecules and phosphatidylinositol 3-kinases. J. Exp. Med. 188 (1998) 1621-1632
35. Mishra R.K., et al. Differential dependence of eosinophil chemotactic responses on phosphoinositide 3-kinase (PI3K). Allergy 60 (2005) 1204-1207
36. Pinho V., et al. Phosphoinositide 3-kinases critically regulate the recruitment and survival of eosinophils in vivo: importance for the resolution of allergic inflammation. J. Leukoc. Biol. 77 (2005) 800-810
37. Duan W., et al. An anti-inflammatory role for a phosphoinositide 3-kinase inhibitor LY294002 in a mouse asthma model. Int. Immunopharm. 5 (2005) 495-502
38. Kwak Y.G., et al. Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J. Clin. Invest. 111 (2003) 1083-1092
39. Myou S., et al. Blockade of inflammation and airway hyperresponsiveness in immune-sensitized mice by dominant-negative phosphoinositide 3-kinase-TAT. J. Exp. Med. 198 (2003) 1573-1582
40. Tigani B., et al. Effects of wortmannin on airway inflammation induced by allergen in actively sensitized Brown Norway rats. Eur. J. Pharmacol. 433 (2001) 217-223